CN112426505A - Chinese patent medicine for treating perimenopausal cardiac neurosis - Google Patents
Chinese patent medicine for treating perimenopausal cardiac neurosis Download PDFInfo
- Publication number
- CN112426505A CN112426505A CN202011428318.1A CN202011428318A CN112426505A CN 112426505 A CN112426505 A CN 112426505A CN 202011428318 A CN202011428318 A CN 202011428318A CN 112426505 A CN112426505 A CN 112426505A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese patent
- patent medicine
- yang
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
The invention belongs to the field of Chinese patent medicines, and provides a Chinese patent medicine for treating perimenopausal cardiac neurosis. The Chinese patent medicine provided by the invention is prepared from the following raw materials: rhizoma Curculiginis, herba Epimedii, radix Morindae officinalis, radix Angelicae sinensis, fructus Ligustri Lucidi, radix Adenophorae, radix Ophiopogonis, radix astragali, ramulus Cinnamomi, Concha Ostreae, rhizoma anemarrhenae, cortex moutan, herba Albiziae, radix Curcumae, flos Abelmoschi Manihot, radix Puerariae, and Glycyrrhrizae radix. The balance of yin and yang in the body of a patient with perimenopausal cardiac neurosis is disordered, the circulation of qi and blood is not smooth, and the function of viscera is disordered; the Chinese patent medicine can regulate yin and yang, so that internal symptoms can communicate yin and yang to keep the middle, warm heart yang, benefit heart qi to help the use of the heart, nourish heart yin to fill the body and cross yang qi of the human body; promoting blood circulation, removing blood stasis, promoting blood circulation, improving myocardial blood supply, and improving physiological function of heart, with clear consciousness, quick thought, and normal emotion, and can be used for treating perimenopausal cardiac neurosis.
Description
Technical Field
The invention belongs to the field of Chinese patent medicines, and particularly relates to a Chinese patent medicine for treating perimenopausal cardiac neurosis.
Background
Perimenopausal cardiac neurosis is a non-organic cardiovascular disease, which refers to a group of symptoms of dysfunction of cardiovascular system of body caused by hypoovarianism and endocrine change in a period of time before and after menopause. The main symptoms are: palpitations or heartache can be manifested as an increased or strengthened heartbeat, or a slow or heavy heartbeat, or a sudden or sudden stop. The secondary symptoms are as follows: hot flashes; insomnia; vertigo; dysesthesia of hands or feet, and swelling of the hands or feet; muscle or joint pain; suffocating; numbness or irritation in the body; it is easy to fatigue or lack of strength. The traditional Chinese medicine does not have the disease name of perimenopausal cardiac neurosis, and can be classified into multiple diseases such as palpitation, chest impediment, cardiodynia, severe palpitation, heart impediment, depression, hysteria and the like.
The cardiac neurosis refers to the transition from middle-aged to old, imbalance of yin and yang in vivo, unsmooth circulation of qi and blood, and palpitation due to visceral dysfunction, accompanied by a series of symptoms and symptoms, which are marked by palpitation, feeling of anxiety in the chest, mental instability, dysphoria, hot face and flush. In the seven-seven years of women, the exhaustion of the sex-stimulating hormone, liver-kidney yin deficiency, yang-qi hyperactivity, surging heat and dysphoria occur, yang is added to yin, so sweating is heart liquid, sweating is heart yin deficiency, yin deficiency and yang appear, heart yang is not vibrating, so the heart chest is oppressed, and perimenopausal cardiac neurosis occurs.
Perimenopausal cardiac neurosis is a chronic disease with multiple factors, multiple layers and mutual influence among the factors, and has difficult effect of western medicine treatment and great side effect. Chinese medicine culture is huge and profound, and the Chinese medicine has the treatment characteristics of multiple components, multiple angles and multiple target points. Therefore, the traditional Chinese medicine has certain advantages in the aspect of treating the perimenopausal cardiac neurosis.
Disclosure of Invention
The invention aims to provide a Chinese patent medicine for treating perimenopausal cardiac neurosis, which has obvious curative effect and stable treatment.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a Chinese patent medicine for treating perimenopausal cardiac neurosis, which is prepared from the following raw materials: rhizoma Curculiginis, herba Epimedii, radix Morindae officinalis, radix Angelicae sinensis, fructus Ligustri Lucidi, radix Adenophorae, radix Ophiopogonis, radix astragali, ramulus Cinnamomi, Concha Ostreae, rhizoma anemarrhenae, cortex moutan, herba Albiziae, radix Curcumae, flos Abelmoschi Manihot, radix Puerariae, and Glycyrrhrizae radix.
Preferably, the feed additive is prepared from the following raw materials in parts by weight: 8-10 parts of curculigo orchioides, 8-10 parts of herba epimedii, 8-10 parts of morinda officinalis, 8-10 parts of angelica sinensis, 8-10 parts of glossy privet fruit, 8-10 parts of adenophora tetraphylla, 8-10 parts of radix ophiopogonis, 6-8 parts of astragalus membranaceus, 6-8 parts of cassia twig, 6-8 parts of oyster, 6-8 parts of rhizoma anemarrhenae, 6-8 parts of cortex moutan, 6-8 parts of albizia julibrissin, 6-8 parts of radix curcumae, 4-6 parts of okra, 4-6 parts of radix puerariae and 2-3 parts of liquorice.
Preferably, the feed additive is prepared from the following raw materials in parts by weight: 9 parts of curculigo orchioides, 9 parts of epimedium herb, 9 parts of morinda officinalis, 9 parts of angelica, 9 parts of glossy privet fruit, 9 parts of adenophora tetraphylla, 9 parts of radix ophiopogonis, 7 parts of astragalus membranaceus, 7 parts of cassia twig, 7 parts of oyster, 7 parts of rhizoma anemarrhenae, 7 parts of cortex moutan, 7 parts of albizia julibrissin, 7 parts of radix curcumae, 5 parts of okra, 5 parts of radix puerariae and 2 parts of liquorice.
The Chinese patent medicine provided by the invention is a pure Chinese medicinal preparation and can be used for treating perimenopausal cardiac neurosis. The balance of yin and yang in the body of a patient with perimenopausal cardiac neurosis is disordered, the circulation of qi and blood is not smooth, and the function of viscera is disordered; the Chinese patent medicine can regulate yin and yang, so that internal symptoms can communicate yin and yang to keep the middle, warm heart yang, benefit heart qi to help the use of the heart, nourish heart yin to fill the body and cross yang qi of the human body; promoting blood circulation, removing blood stasis, promoting blood circulation, improving myocardial blood supply, and normalizing physiological function of heart governing mind, clear consciousness, quick thought, and normal emotion. Has good improvement effect on perimenopausal cardiac neurosis and ensures the safety of treatment.
Detailed Description
The invention provides a Chinese patent medicine for treating perimenopausal cardiac neurosis, which can comprehensively condition the perimenopausal cardiac neurosis, has the advantages of definite curative effect and low cost, has a better effect on improving the Chinese medical symptoms, and ensures the safety of treatment. The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
A Chinese patent medicine for treating perimenopausal cardiac neurosis is prepared from the following raw materials in parts by weight: 9 parts of curculigo orchioides, 9 parts of epimedium herb, 9 parts of morinda officinalis, 9 parts of angelica, 9 parts of glossy privet fruit, 9 parts of adenophora tetraphylla, 9 parts of radix ophiopogonis, 7 parts of astragalus membranaceus, 7 parts of cassia twig, 7 parts of oyster, 7 parts of rhizoma anemarrhenae, 7 parts of cortex moutan, 7 parts of albizia julibrissin, 7 parts of radix curcumae, 5 parts of okra, 5 parts of radix puerariae and 2 parts of liquorice.
Mixing the raw materials in parts by weight, processing into powder, and then processing into water-bindered pills.
Example 2
A Chinese patent medicine for treating perimenopausal cardiac neurosis is prepared from the following raw materials in parts by weight: 8 parts of curculigo orchioides, 8 parts of epimedium, 8 parts of morinda officinalis, 10 parts of angelica, 10 parts of glossy privet fruit, 10 parts of adenophora tetraphylla, 10 parts of radix ophiopogonis, 6 parts of astragalus membranaceus, 6 parts of cassia twig, 7 parts of oyster, 8 parts of rhizoma anemarrhenae, 6 parts of cortex moutan, 6 parts of albizia julibrissin, 6 parts of radix curcumae, 4 parts of okra, 6 parts of radix puerariae and 3 parts of liquorice.
Mixing the raw materials in parts by weight, processing into powder, and then processing into water-bindered pills.
Example 3
A Chinese patent medicine for treating perimenopausal cardiac neurosis is prepared from the following raw materials in parts by weight: 10 parts of curculigo orchioides, 10 parts of epimedium, 8 parts of morinda officinalis, 8 parts of angelica sinensis, 10 parts of glossy privet fruit, 10 parts of adenophora tetraphylla, 10 parts of radix ophiopogonis, 8 parts of astragalus membranaceus, 8 parts of cassia twig, 8 parts of oyster, 6 parts of rhizoma anemarrhenae, 8 parts of cortex moutan, 8 parts of albizia julibrissin, 8 parts of radix curcumae, 6 parts of okra, 4 parts of radix puerariae and 2 parts of liquorice.
Mixing the raw materials in parts by weight, processing into powder, and then processing into water-bindered pills.
It should be specially noted that the invention can also be processed into various Chinese patent medicine preparations according to the existing medicine technology.
Case 1
Patient female, 50 years old, menopausal for 1 year. Because the patient is diagnosed with repeated chest distress for 10 years, chest pain for 1 year and 10 days again, the patient suffers from chest distress, profuse sweat and dizziness after being frightened for a month, the symptoms are relieved automatically after lasting for a plurality of minutes, and the patient does not have the discomfort of chest pain, palpitation and the like and has insomnia for more than 10 continuous days. Thereafter, chest distress, repeated dizziness and fatigue can occur. Dynamic electrocardiogram prompting: sinus bradycardia, occasional atrial premature beats, and ST-T global abnormal changes, and is diagnosed as perimenopausal cardiac neurosis. After the Chinese patent medicine prepared in the embodiment 1 of the invention is taken, 10g of the medicine is taken once, 3 times a day, 3 weeks and 1 treatment course, and 3 treatment courses are taken in total, so that chest distress and dizziness symptoms disappear, no hyperhidrosis and hypodynamia symptoms exist, and the treatment effect is good.
Case 2
The patient is female, 46 years old, irregular menstruation for more than 1 year. The physician needs to see the disease for more than 10 days of insomnia due to palpitation (6 months). Chest pain, chest distress, profuse sweat, dizziness, trembling hands and feet, no discomfort such as short breath, palpitation, headache, nausea, vomiting and the like appear in a week, and the discomfort is relieved automatically after the duration of 2 minutes. And (3) electrocardiogram prompting: sinus tachycardia, diagnosed as "perimenopausal cardiac neurosis". After the Chinese patent medicine prepared in the embodiment 2 of the invention is taken, 10g of the medicine is taken once, 3 times a day, 3 weeks and 1 treatment course, and the taking of the medicine for 2 treatment courses totally disappears the symptoms of palpitation, chest pain and chest distress, the symptoms of hyperhidrosis and dizziness do not exist, and the sleep is obviously improved.
Case 3
The patient is a female, 44 years old, irregular menstruation for more than half a year. The physician needs to be diagnosed for palpitation of 3 months, hyperhidrosis, hectic fever, chest distress and chest pain of more than 1 month. And (3) electrocardiogram prompting: sinus bradycardia, occasional atrial premature beat. The diagnosis is "perimenopausal cardiac neurosis". After the Chinese patent medicine prepared in the embodiment 1 of the invention is taken, 10g of the Chinese patent medicine is taken once, 3 times a day, 3 weeks and 1 treatment course, and 2 treatment courses are taken in total, so that palpitation symptoms disappear, chest distress and pain, hectic fever and night sweat do not exist, and an electrocardiogram shows that: the curative effect is obvious for sinus rhythm.
The Chinese patent medicine of the invention obviously relieves the symptoms of more than 500 patients with perimenopausal cardiac neurosis, and has obvious curative effect and stable treatment.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (3)
1. A Chinese patent medicine for treating perimenopausal cardiac neurosis is characterized by being prepared from the following raw materials: rhizoma Curculiginis, herba Epimedii, radix Morindae officinalis, radix Angelicae sinensis, fructus Ligustri Lucidi, radix Adenophorae, radix Ophiopogonis, radix astragali, ramulus Cinnamomi, Concha Ostreae, rhizoma anemarrhenae, cortex moutan, herba Albiziae, radix Curcumae, flos Abelmoschi Manihot, radix Puerariae, and Glycyrrhrizae radix.
2. The Chinese patent medicine for treating perimenopausal cardiac neurosis according to claim 1, which is prepared from the following raw materials in parts by weight: 8-10 parts of curculigo orchioides, 8-10 parts of herba epimedii, 8-10 parts of morinda officinalis, 8-10 parts of angelica sinensis, 8-10 parts of glossy privet fruit, 8-10 parts of adenophora tetraphylla, 8-10 parts of radix ophiopogonis, 6-8 parts of astragalus membranaceus, 6-8 parts of cassia twig, 6-8 parts of oyster, 6-8 parts of rhizoma anemarrhenae, 6-8 parts of cortex moutan, 6-8 parts of albizia julibrissin, 6-8 parts of radix curcumae, 4-6 parts of okra, 4-6 parts of radix puerariae and 2-3 parts of liquorice.
3. The Chinese patent medicine for treating perimenopausal cardiac neurosis according to claim 1 or 2, which is prepared from the following raw materials in parts by weight: 9 parts of curculigo orchioides, 9 parts of epimedium herb, 9 parts of morinda officinalis, 9 parts of angelica, 9 parts of glossy privet fruit, 9 parts of adenophora tetraphylla, 9 parts of radix ophiopogonis, 7 parts of astragalus membranaceus, 7 parts of cassia twig, 7 parts of oyster, 7 parts of rhizoma anemarrhenae, 7 parts of cortex moutan, 7 parts of albizia julibrissin, 7 parts of radix curcumae, 5 parts of okra, 5 parts of radix puerariae and 2 parts of liquorice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011428318.1A CN112426505A (en) | 2020-12-09 | 2020-12-09 | Chinese patent medicine for treating perimenopausal cardiac neurosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011428318.1A CN112426505A (en) | 2020-12-09 | 2020-12-09 | Chinese patent medicine for treating perimenopausal cardiac neurosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112426505A true CN112426505A (en) | 2021-03-02 |
Family
ID=74692043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011428318.1A Pending CN112426505A (en) | 2020-12-09 | 2020-12-09 | Chinese patent medicine for treating perimenopausal cardiac neurosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112426505A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1380081A (en) * | 2002-04-24 | 2002-11-20 | 上海中医药大学 | Chinese medicine preparation containing curculigo rhizome and epimedium and its preparation method |
-
2020
- 2020-12-09 CN CN202011428318.1A patent/CN112426505A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1380081A (en) * | 2002-04-24 | 2002-11-20 | 上海中医药大学 | Chinese medicine preparation containing curculigo rhizome and epimedium and its preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 夏桂成: "《月经病中医诊治》", 30 June 2001, 人民卫生出版社 * |
| 罗承锋等: "温肾阳为主治疗女性更年期综合征心悸", 《吉林中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN102114231B (en) | Medicine for treating arrhythmia | |
| CN102349985A (en) | Traditional Chinese medicine composition for treating chronic arrhythmias | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN101254266B (en) | Cardiac and cerebral vascular disease treating medicine | |
| CN101554471B (en) | Traditional Chinese medicine preparation for treating myocardial infarction | |
| CN103251735A (en) | Chinese medicine for treating paroxysmal supraventricular tachycardia | |
| CN102861169B (en) | Traditional Chinese medicine compound for treating paroxysmal supraventricular tachycardia | |
| CN112426505A (en) | Chinese patent medicine for treating perimenopausal cardiac neurosis | |
| CN101579509B (en) | Traditional Chinese medicine preparation for treating premature beat of cardiac rhythm | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103007217A (en) | Chinese medicinal composition for treating hypotension | |
| CN102430085A (en) | Chinese medicine for treating coronary heart disease | |
| CN102579804B (en) | Chinese medicine for treating stenocardia | |
| CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
| CN102462751A (en) | Chinese medicine for treating arrhythmia and preparation method thereof | |
| CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN103599485B (en) | A kind of Chinese medicine composition being used for the treatment of premature beat | |
| CN115814020B (en) | Traditional Chinese medicine composition for treating ventricular arrhythmia and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210302 |